Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VVivos Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Vivos Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 14, 2026JOHNSON GREGG CDirector12,000Stock Options (Right to Buy)$2.2KGrant / award
Sep 14, 2026SOKOLOW LEONARD JDirector12,000Stock Options (Right to Buy)$2.2KGrant / award
Jul 31, 2026Amman Bradford K.Principal Accounting Officer150,000Stock Option (Right to Buy)$61.5KGrant / award
Jul 31, 2026Amman Bradford K.Principal Accounting Officer250,000Common Stock$102.5KGrant / award
Jun 30, 2026Huntsman Ronald KirkChief Executive Officer85,910Warrant (Right to Buy)$38.7KOther
Jun 30, 2026Huntsman Ronald KirkChief Executive Officer85,910Preferred Stock$38.7KOther
Jun 30, 2026Skaff Michael C10% Owner2,749,330Common Stock Purchase Warrant$1.2MBuy
Jun 30, 2026Skaff Michael C10% Owner2,749,330Series A Convertible Preferred Stock$1.2MBuy
Mar 31, 2026Skaff Michael C10% Owner1,783,582Series B Common Stock Warrant$2.1MBuy
Mar 31, 2026Skaff Michael C10% Owner1,783,582Series A Common Stock Warrant$2.1MBuy
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.16Close ยท Sep 22, 2026